Meiling Chen,Nesren A. H. Saada,Fei Liu,Haining Na,Jin Zhu
Lauric diacid (LCDA), also known as 1,12-dodecanedioic acid, is used to develop a series of copolyesters along with 1,4-cyclohexanedicarboxylic acid (CHDA) and 1,4-butanediol (BDO). The resulting poly(butylene lauric dicarboxylate-co-butylene 1,4-cyclohexanedicarboxylate) (PBLC) is proved to be a random copolyester with three triad sequences. When the LCDA content increases from 20 to 60 mol%, Tm of the copolyester decreases from 133 to 57 °C. At the same time, the tensile modulus and strength decrease from 94 and 14 MPa to 40 and 5 MPa, respectively. Moreover, the elongation at break also drops from 640 to only 50%. However, further increasing the LCDA content to 80 mol%, the copolyester becomes amorphous with no Tm, and its tensile modulus, strength, and the elongation at break all improve significantly to 68 and 7 MPa, and over 1400%, respectively. More importantly, for the homo-polymer poly(butylene lauric dicarboxylate) (PBL), it has a relatively high Tm of 73 °C compared to that of polycaprolactone (PCL), but lower tensile modulus and strength, and significantly higher ductility, compared to those of PCL, linear low density polyethylene, and polybutylene succinate.
Mannose-diester lauric diacid-cholesterol (Man-DLD-Chol), as a liposomal target ligand, was synthesized by lipase catalyzed in a non-aqueous medium. Its chemical structure was confirmed by mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy. Glycyrrhetinic acid (GA) liposomes containing Man-DLD-Chol (Man-DLD-Chol-GA-Lp) were prepared by the film-dispersion method. We evaluated the characterizations of liposomes, drug-release in vitro, the hemolytic test, cellular uptake, pharmacokinetics, and the tissue distributions. The cellular uptake in vitro suggested that the uptake of Man-DLD-Chol-modified liposomes was significantly higher than that of unmodified liposomes in HepG2 cells. Pharmacokinetic parameters indicated that Man-DLD-Chol-GA-Lp was eliminated more rapidly than GA-Lp. In tissue distributions, the targeting efficiency (Te) of Man-DLD-Chol-GA-Lp on liver was 54.67%, relative targeting efficiency (RTe) was 3.39, relative uptake rate (Re) was 4.78, and peak concentration ratio (Ce) was 3.46. All these results supported the hypothesis that Man-DLD-Chol would be an efficient liposomal carrier, and demonstrated that Man-DLD-Chol-GA-Lp has potential as a drug delivery for liver-targeting therapy.Keywords:lipase-catalytic acylation;mannose-diester lauric diacid-cholesterol;glycyrrhetinic acid liposomes;mannose receptor;liver-targeting
危险品化学品经营许可证（带存储）